최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Pharmacoepidemiology and drug safety, v.18 no.10, 2009년, pp.910 - 915
Shin, Yoo Seob (Korean Association of Regional Pharmacovigilance Centers, Yonsei University College of Medicine, Seoul, Korea) , Lee, Yong-Won (Korean Association of Regional Pharmacovigilance Centers, Yonsei University College of Medicine, Seoul, Korea) , Choi, Young Hwa (Korean Association of Regional Pharmacovigilance Centers, Yonsei University College of Medicine, Seoul, Korea) , Park, Byungjoo (Korean Association of Regional Pharmacovigilance Centers, Yonsei University College of Medicine, Seoul, Korea) , Jee, Young Koo (Korean Association of Regional Pharmacovigilance Centers, Yonsei University College of Medicine, Seoul, Korea) , Choi, Sung-Kyu (Korean Association of Regional Pharmacovigilance Centers, Yonsei University College of Medicine, Seoul, Korea) , Kim, Eung-Gyu (Korean Association of Regional Pharmacovigilance Centers, Yonsei University College of Medicine, Seoul, Korea) , Park, Jung-Won (Korean Association of Regional Pharmacovigilance Centers, Yonsei University College of Medicine, Seoul, Korea) , Hong, Chein-Soo (Korean Association of Regional Pharmacovigilance Centers, Yonsei University College of Medicine, Seoul,)
PurposePatterns of prescriptions are markedly influenced by regional disease entities, medical education, culture, economic status, and available pharmaceutical companies. Features of adverse drug reactions (ADRs) may vary in different countries. In this study, we analyzed the causative drugs and cl...
Leape, Lucian L., Brennan, Troyen A., Laird, Nan, Lawthers, Ann G., Localio, A. Russell, Barnes, Benjamin A., Hebert, Liesi, Newhouse, Joseph P., Weiler, Paul C., Hiatt, Howard. The Nature of Adverse Events in Hospitalized Patients : Results of the Harvard Medical Practice Study II. The New England journal of medicine, vol.324, no.6, 377-384.
Bates, D W, Cullen, D J, Laird, N, Petersen, L A, Small, S D, Servi, D, Laffel, G, Sweitzer, B J, Shea, B F, Hallisey, R. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.. JAMA : the journal of the American Medical Association, vol.274, no.1, 29-34.
Roughead, Elizabeth E, Gilbert, Andrew L, Sansom, Lloyd N, Primrose, John G. Drug‐related hospital admissions: a review of Australian studies published 1988‐1996. Medical journal of Australia, vol.168, no.8, 405-408.
Classen, D C, Pestotnik, S L, Evans, R S, Lloyd, J F, Burke, J P. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.. JAMA : the journal of the American Medical Association, vol.277, no.4, 301-306.
J R Coll Physicians Lond Rawlins MD 41 29 1995 Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994
Eliasson, Erik. Ethnicity and adverse drug reactions. BMJ : British medical journal, vol.332, no.7551, 1163-1164.
Camargo, Aline Lins, Cardoso Ferreira, Maria Beatriz, Heineck, Isabela. Adverse drug reactions: a cohort study in internal medicine units at a university hospital. European journal of clinical pharmacology, vol.62, no.2, 143-149.
Edwards, I Ralph, Aronson, Jeffrey K. Adverse drug reactions: definitions, diagnosis, and management. The Lancet, vol.356, no.9237, 1255-1259.
Hunziker, Th., Künzi, U.‐P., Braunschweig, S., Zehnder, D., Hoigné, R.. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20‐year survey. Allergy, vol.52, no.4, 388-393.
Thong, Bernard Yu-Hor, Leong, Khai-Pang, Tang, Chwee-Ying, Chng, Hiok-Hee. Drug allergy in a general hospital: results of a novel prospective inpatient reporting system. Annals of allergy, asthma, & immunology, vol.90, no.3, 342-347.
Korean J Med Choi JH 290 67 2004 The frequency of adverse drug reactions in a tertiary care hospital in Korea
Bates, D W, Miller, E B, Cullen, D J, Burdick, L, Williams, L, Laird, N, Petersen, L A, Small, S D, Sweitzer, B J, Vander Vliet, M, Leape, L L. Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group.. Archives of internal medicine, vol.159, no.21, 2553-2560.
Classen, D C. Computerized surveillance of adverse drug events in hospital patients. Quality & safety in health care, vol.14, no.3, 221-226.
Lacoste‐Roussillon, Caroline, Pouyanne, Pierre, Haramburu, Françoise, Miremont, Ghada, Bégaud, Bernard. Incidence of serious adverse drug reactions in general practice: A prospective study. Clinical pharmacology and therapeutics, vol.69, no.6, 458-462.
Gandhi, Tejal K., Burstin, Helen R., Cook, E. Francis, Puopolo, Ann L., Haas, Jennifer S., Brennan, Troyen A., Bates, David W.. Drug complications in outpatients. Journal of general internal medicine : official journal of the Society for Research and Education in Primary Care Internal Medicine, vol.15, no.3, 149-154.
Lazarou, J, Pomeranz, B H, Corey, P N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.. JAMA : the journal of the American Medical Association, vol.279, no.15, 1200-1205.
Stricker, Bruno HCh, Psaty, Bruce M. Detection, verification, and quantification of adverse drug reactions. BMJ : British medical journal, vol.329, no.7456, 44-47.
Faich, Gerald A.. Adverse-Drug-Reaction Monitoring. The New England journal of medicine, vol.314, no.24, 1589-1592.
JICK, H. Adverse drug reactions: The magnitude of the problem. The Journal of allergy and clinical immunology : official organ of American Academy of Allergy, vol.74, no.4, 555-557.
Am J Hosp Pharm Berry LL 1534 45 1988 Sensitivity and specificity of three methods of detecting adverse drug reactions
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.